Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase

Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase
Ebos CEO John Cullity doesn't want to pre-empt regulators. (Image: supplied)
Jenny Ruth
Ebos Group's purchase of the LifeHealthcare business is unlikely to have trouble clearing competition watchdogs on either side of the Tasman since its existing medical devices business is quite small.Ebos bought the LMT and National Surgical businesses in late 2019 for A$34 million compared with the LifeHealthcare purchase price of A$1.17 billion.In August last year, it also announced the purchase of Pioneer Medical, a New Zealand-based importer and distributor of spine and major joint implants and associated surgical technologies.Ebos didn...

More Infrastructure

Consolidation on the cards as cash no longer king
Economy

Consolidation on the cards as cash no longer king

Cash use has declined for two decades. 

Rebecca Howard 28 Mar 2024
Bridge collapse to cause traffic delays for US car exports
Infrastructure

Bridge collapse to cause traffic delays for US car exports

Industry was just starting to recover after covid pandemic. 

Bloomberg 28 Mar 2024
Councils need to get their mojo back: Anne Tolley
Infrastructure

Councils need to get their mojo back: Anne Tolley

She says local bodies need to take up the funding tools already available to them.

Oliver Lewis 28 Mar 2024
Steven Joyce to chair group looking at infrastructure agency
Infrastructure

Steven Joyce to chair group looking at infrastructure agency

The new National Infrastructure Agency will be up and running next year.

Oliver Lewis 26 Mar 2024